摘要
在过去20多年里,学者们从流行病学、临床病理和分子遗传学等方面对子宫内膜癌进行了大量的研究,关于其发病机制,
出处
《中华妇产科杂志》
CAS
CSCD
北大核心
2011年第6期472-475,共4页
Chinese Journal of Obstetrics and Gynecology
参考文献27
-
1Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gyneeol Oneol, 1983, 15:10-17.
-
2Sagr ER, Denschlag D, Kerim-Dikeni A, et al. Prognostic factors and treatment-related outcome in patients with uterine papillary serous carcinoma. Anticancer Res, 2007, 27 : 1213-1217.
-
3Wheeler DT, Bell KA, Kurman RJ, et al. Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation. Am J Surg Pathol, 2000, 24:797-$06.
-
4Atnbros RA, Sherman ME, Zahn CM, et al. Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol, 1995, 26: 1260-1267.
-
5Zheng W, Khurana R, Farahmand S, et al. p53 itmnunostaining as a significant adjunct diagnostic method for uterine surface carcinoma: precursor of uterine papillary sm'ous carcinoma. Am J SHrg Pathol, 1998, 22:1463-1473.
-
6Zheng W, Schwartz PE. Serous EIC as an early form of uterine papillary serous carcinoma: recent progress in understanding its pathogenesis and current opinions regarding pathologic and clinical management. Gynecol Oncol, 2005, 96 :579-582.
-
7Zhcng W, Liang SX, Yu H, et al. Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I : morphologic ieatures, lnt J Surg Pathol, 2004, 12:207-223.
-
8Zheng W, Cao P, Zheng M, et al. p53 overexprcssion and bcl-2 persistence in endometrial carcinoma: comparison of papillary serous and endometrioid subtypes. Gynecol Oncol, 1996, 61: 167-174.
-
9Liang SX, Chambers SK, Cheng L, et al. Endometrial glandular dysplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part lI :molecular features. Int J Snrg Pathol, 2004, 12:319-331.
-
10Jia L, Liu Y, Yi X, et al. Endometrial ghmdular dysplasia with frequent p53 gene mutation: a genetic evidenee supporting its preeancer nature for eudometrial serous carcinoma. Clin CancerRes, 2008, 14:2263-2269.
同被引文献27
-
1王慧君,郑文新.Ⅱ型子宫内膜癌的前驱病变及其发生模式[J].中华病理学杂志,2007,36(8):505-507. 被引量:5
-
2del Carmen MG, Birrer M, Schorge JO. Uterine papillary serous cancer: A review of the literature [J]. Gynecol Oncol, 2012,127 (3) :651-661.
-
3Eavie O, Ben-Arie A, Gemer O. Possible association between BRCA-1 carriers and incidence of uterine papillary serous carcinoma (UPSC) [J]. lnt J Gynecol Cancer, 2008,18 (5) : 1150-1150.
-
4Morgan J, Hoekstra AV, Chapman-Davis E, et al. Synuclein-ga (SNCG) may be a novel prognostic biomarker in uterine papillary serous carcinoma [ J ]. Gynecol Oncol, 2009,114 (2) : 293-298.
-
5Zheng W, Liang SX, Yu H, et al. Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features [J]. lnt J Surg Pathol, 2004, 12 (3) : 207-223.
-
6Yi X, Zheng W. Endometrial glandular dysplasia and endometrial intraepithelial neoplasia [J]. Curt Opin Obstet Gynecol, 2008, 20( 1 ) : 20-25.
-
7Signorelli M, Guerra L, Buda A, et al. Role of the integrated PDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases [J]. Gynecol Oncol, 2009,115 (2) :231 - 235.
-
8Moore KN, Fader AN. Uterine Papillary Serous Carcinoma [J]. Clin Obstet Gynecol, 2011,54(2) :278-291.
-
9Ikeda Y, Oda K, Hiraike-Wada O, et al. Cyclin D1 harboring the T286I mutation promotes oncogenic activation in endometrial cancer [J]. Oncol Rep, 2013,30(2):584-588.
-
10Kontos CK, Scorilas A. Kallikrein-related peptidases (KLKs) : a gene family of novel cancer biomarkers [J]. Clin Chem Lab Med, 2012,50( 11 ) : 1877-1891.
引证文献3
-
1李岩,耿晓星.子宫内膜浆液性乳头状癌的研究新进展[J].实用医学杂志,2014,30(6):869-870. 被引量:1
-
2魏丽,刘鹏,刘萌萌,刘若慧.P16与P53在子宫内膜浆液性腺癌与子宫内膜样腺癌鉴别诊断中的作用[J].中国临床新医学,2016,9(11):990-993. 被引量:2
-
3韩瑛,刘崇东.子宫浆液性癌的起源及临床研究进展[J].中国实用妇科与产科杂志,2020,36(8):779-781.
二级引证文献3
-
1岳会珠,王桂菊,许丽.P16、P53联合检测在子宫内膜样癌与子宫内膜浆液性癌鉴别诊断中的意义[J].医药论坛杂志,2018,39(9):85-86.
-
2黄伟,苗昊,彭林.LncRNA-OVAAL的表达与子宫内膜浆液性乳头状癌患者术后复发和预后的关系[J].中国医师杂志,2020,22(2):216-219. 被引量:4
-
3周冰洁,朱任坚.子宫内膜浆液性腺癌1例分析[J].科学中国人,2017(7Z):65-65.
-
1杨慧,孙立新.Ⅱ型子宫内膜癌研究进展[J].肿瘤研究与临床,2016,28(4):276-279. 被引量:7
-
2侯兴华,李春杨,金素芬.子宫内膜浆液性癌腋下淋巴结转移1例[J].临床与实验病理学杂志,2013,29(3):348-349. 被引量:4
-
3王慧君,郑文新.Ⅱ型子宫内膜癌的前驱病变及其发生模式[J].中华病理学杂志,2007,36(8):505-507. 被引量:5
-
4杨振宇,樊志文,张雷.肺腺癌发展模式[J].国际肿瘤学杂志,2013,40(2):120-122. 被引量:1
-
5熊汉真,刘少颜,杨嶽鑫,林琼燕,江庆萍.子宫内膜癌中PTEN与PI3K-Akt通路的表达及意义[J].现代生物医学进展,2014,14(19):3699-3702.
-
6王燕利,王武亮.早期特殊类型子宫内膜癌全面分期术后辅助化疗的临床意义[J].中国妇产科临床杂志,2016,17(4):313-315. 被引量:2
-
7张廷国,郑文新.子宫内膜浆液性癌及其癌前病变的概念和诊断进展[J].中华病理学杂志,2012,41(11):724-726. 被引量:5
-
8种树彬,杨柳.乳腺癌癌前病变的癌变机制研究进展[J].现代中西医结合杂志,2007,16(25):3758-3759. 被引量:3
-
9赵玲玲,赵涌,李园园,林晓.PTEN、p53在子宫内膜浆液性癌和宫内膜样癌中的表达及临床病理意义[J].现代肿瘤医学,2005,13(4):468-470.
-
10Zheng W,Yi X,Fadare O,潘敏鸿(摘译),周晓军(审校).癌胚蛋白IMP3:子宫内膜浆液性癌的新标记物[J].临床与实验病理学杂志,2008,24(3):283-283.